Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Enrolling in Clinical Research While Incarcerated: What Influences Participants' Decisions?
Gene therapy approaches for the treatment of retinal disorders.
Mahoney, Amy
MEKK2 mediates aberrant ERK activation in neurofibromatosis type I.
AAV-based in vivo gene therapy for neurological disorders.
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AAV-based in vivo gene therapy for neurological disorders.
Ling Q, Herstine JA, Bradbury A, Gray SJ. AAV-based in vivo gene therapy for neurological disorders. Nat Rev Drug Discov. 2023 10; 22(10):789-806.
View in:
PubMed
subject areas
Dependovirus
Genetic Therapy
Genetic Vectors
Humans
Models, Biological
Nervous System Diseases
Transgenes
authors with profiles
Qinglan Ling PhD